Rhino Biotech Limited
Rhino Biotech Limited (RBRXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RBRXF · as of Jun 9, 2026
Key Statistics
Explore Rhino Biotech Limited Data
rbrxf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
rbrxf competitorsRBRXF
AFHIF
ANSU
CONC
EXCL
LRDRStock Performance
Full HistoryAbout Rhino Biotech Limited
Rhino Biotech Limited is dedicated to pioneering the development of health supplements sourced from plants and fungi, in addition to biopharmaceutical solutions designed for both disease prevention an…
what is rhino biotech limited · rbrxf stock overview · rhino biotech limited company profile · who is rhino biotech limited ceo · rbrxf OTC · rhino biotech limited headquarters · rhino biotech limited business segments
About Stock Overview & Key Data
Rhino Biotech Limited (RBRXF) is a Financial Services company in the Shell Companies industry, listed on OTC since Feb 4, 2005. As of the latest trading session, RBRXF stock price is $0.00, with a market capitalization of $3,105. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Rhino Biotech Limited reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rhino Biotech Limited (RBRXF) stock price is $0.00. The stock is traded on OTC under the ticker symbol RBRXF. The 52-week range is $0.00 – $0.00.